Acute management of adult MOG antibody–associated disease: therapeutic choices and clinical outcomes
Expert Opinion on Emerging Drugs | June 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-5
10.1080/14728214.2026.2689745